Baker Bros. Advisors LP Kura Oncology, Inc. Transaction History

Baker Bros. Advisors LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$10.71 - $18.33 $2.94 Million - $5.03 Million	-274,458 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$11.78 - $16.98 $349,866 - $504,306	-29,700 Reduced 9.76%	274,458 $4.41 Million
Q3 2021 Nov 15, 2021	BUY	$15.42 - $21.72 $4.69 Million - $6.61 Million	304,158 New	304,158 $5.7 Million

173

80.4M

914K

120K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $1.38B
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.